UIC-2019-010 – A new use for the GlyB4 biologic for neurodegenerative disease

Neuroinflammation and plaque formation are a high risk for the development of neurological diseases. The initial inflammatory response can be regarded as a defense/protective reaction mechanism, but its further amplification, speeds up neurodegenerative diseases Among these, Alzheimer’s disease (AD) is the seventh leading cause of death among all ages and the third most expensive illness […]

UIC-2017-104 – The LEAD Experience (Legislative Education & Advocacy Development)

The Legislative Education and Advocacy Development program (LEAD) is an educational course designed to provide health professionals with the tools needed to communicate with legislators about health policy issues The LEAD Experience aims to produce individuals who are capable of affecting political change by effectively analyzing health policy and conveying their analyses to legislators Participants […]

UIC-2016-085 – Lineage Conversion of Human Fibroblasts to Erythro-Angioblasts Generates Functional Endothelial Cells and Erythrocytes

Ischemic heart disease (IHD) is the leading cause of death and disability worldwide and affects 17,600,000 Americans, causing the U.S. approximately $108 billion in treatment and management of myocardial ischemia Current treatment options include injection of an anticoagulant, thrombolysis, embolectomy, surgical revascularisation, or amputation, none of which help the regeneration of new blood vessels or […]

UIC-2010-079 – A Novel Prostate Cancer Vaccine

Prostate cancer is the second leading cause of cancer death among men in the US. It is estimated that more than 200,000 new cases are diagnosed every year and approximately 30,000 will die of this disease. This cancer can be diagnosed at an early stage, but there are few effective treatment options for early stage […]